KERX: Keryx Biopharmaceuticals, Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Keryx Biopharmaceuticals, Inc.

NASDAQ:KERX

SummaryFactSheetFinancial
Notice
Stock data is unavailable or the company’s delisted.
Price
$3.36
Loss Chance
51.0%
3.45JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Related
Alexion Pharmaceuticals
NASDAQ:ALXN
6.89
$182.50
52.20%
Amgen
NASDAQ:AMGN
6.24
$331.70
35.87%
Arena Pharmaceuticals
NASDAQ:ARNA
0.01
$99.99
100.00%
Biogen
NASDAQ:BIIB
5.83
$193.45
12.40%
Celgene Corporation
NASDAQ:CELG
8.55
$108.24
17.72%
Jitta Factors
Growth Opportunity (61)
Recent Business Performance (65)
Financial Strength (0)
Return to Shareholders (0)
Competitive Advantage (7)
Jitta Signs
Operating MarginDeclined
Recent Business PerformanceEarning decline 28.42% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
3.45
100.00%
2.20
144.61%
n/a
n/a
Biotechnology
6.24
35.87%
0.01
100.00%
5.83
12.40%
COMPANY DESCRIPTION
Keryx Biopharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on providing medicines for patients with kidney disease in the United States. It markets its lead product Auryxia (ferric citrate), an orally available, absorbable, iron-based medicine for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis, as well as for the treatment of iron deficiency anemia in adults with CKD not on dialysis. The company has strategic alliances with Japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. for the development and commercialization of ferric citrate in Japan; and with Panion & BF Biotech, Inc. for the development and marketing of ferric citrate. Keryx Biopharmaceuticals, Inc. was founded in 1997 and is headquartered in Boston, Massachusetts. As of December 12, 2018, Keryx Biopharmaceuticals, Inc. operates as a subsidiary of Akebia Therapeutics, Inc.
www.keryx.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.